Patent details

Basic Information

Publication number:

EP3173427

WO Application Number:

Type:

European Patent Granted for NL

Status:

Patent in Force

Publication Title:

Title When Made Available For Viewing:

Reason Lapsed:

Application number:

EP16190193.9

WO Publication Number:

EPO Publication Language:

English

SPC Number:

First Applicant Residence Country:

Switzerland (CH)

Publications:

Dates

Filing date:

28/03/2012

Grant date:

19/06/2019

EP Publication Date:

31/05/2017

WO Publication Date:

Claims Translations Received Date:

Claims Translation B1 Received Date:

20/08/2019

Claims Translation B2 Received Date:

Claims Translation B3 Received Date:

Lapsed By Non Payment Annual Fee Date:

Renunciation Date:

NullificationDate:

Published:

Due To Cession Date:

Registration date:

19/06/2019

EP B1 Publication Date:

19/06/2019

EP B2 Publication Date:

EP B3 Publication Date:

Description Translation B1 Received Date:

Description Translation B2 Received Date:

Description Translation B3 Received Date:

Expiration date:

27/03/2032

Lapsed By Expiration Date:

Patent Validated Date:

23/08/2019

Revocation Date:

Invalidity Date:

Response To Novelty Search Report Received:

Patent Granting Request:

Lapsed date:

Applicant/holder

From:

19/06/2019

 

 

 

Name:

ADC Therapeutics SA

Address:

Biopôle Route de la Corniche 3B, 1066 Epalinges, Switzerland (CH)

Agent

Name:

ir. M.F.J.M. Ketelaars c.s.

From:

22/08/2019

Address:

NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)

To:

Inventor

1

Name:

Tremblay, Gilles Bernard

Address:

La Prairie Québec J5R 6N8, Canada (CA)

2

Name:

Moraitis, Anna N.

Address:

Laval Québec H7W 1Z4, Canada (CA)

3

Name:

Sulea, Traian

Address:

Kirkland Québec H9J 3A2, Canada (CA)

4

Name:

Filion, Mario

Address:

Longueuil Québec J4J 4M8, Canada (CA)

Pledgee

Name:

Owl Rock Opportunistic Master Fund I, L.P.

Address:

399 Park Avenue, 38th FL, 10022, New York, NY, United States of America (US)

Priority

1

Priority Patent Number:

201161533346 P

Priority Date:

12/09/2011

Priority Country:

United States of America (US)

2

Priority Patent Number:

201161470063 P

Priority Date:

31/03/2011

Priority Country:

United States of America (US)

Classification

IPC or IDT classification:

A61K 39/395; A61P 35/00; A61P 35/04; C07K 16/30; G01N 33/574;

Publication

Bulletin

1

Bulletin Heading:

MED

Journal edition number:

47/23

Publication date:

22/11/2023

Description:

Other communications

2

Bulletin Heading:

MED

Journal edition number:

40/22

Publication date:

05/10/2022

Description:

Other communications

3

Bulletin Heading:

MED

Journal edition number:

29/20

Publication date:

14/08/2020

Description:

Other communications

4

Bulletin Heading:

EP3

Journal edition number:

35/19

Publication date:

28/08/2019

Description:

European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

5

Bulletin Heading:

EP2

Journal edition number:

25/19

Publication date:

19/06/2019

Description:

European patents granted for the Netherlands

European Patent Bulletin

Issue number:

201925

Publication date:

19/06/2019

Description:

Grant (B1)

Deed

Right of Pledge

Change Kind/ Decision Type:

Removed

Deed Number:

RC202302251A

Date Registered:

08/11/2023

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

dr. R.C. van Duijvenbode c.s.

Journal Edition Number:

Text:

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Removed Pledgee(s)

Name:

Deerfield Partners, L.P.

Address:

780 Third Avenue, 37th Floor, 10017, New York, NY, United States of America (US)

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

Right of Pledge

Change Kind/ Decision Type:

Established

Deed Number:

RC202202466C

Date Registered:

27/09/2022

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

dr. R.C. van Duijvenbode c.s.

Journal Edition Number:

Text:

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Added Pledgee(s)

Name:

Owl Rock Opportunistic Master Fund I, L.P.

Address:

399 Park Avenue, 38th FL, 10022, New York, NY, United States of America (US)

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

Right of Pledge

Change Kind/ Decision Type:

Established

Deed Number:

RC202001210B

Date Registered:

25/06/2020

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

ir. M.F.J.M. Ketelaars c.s.

Journal Edition Number:

Text:

Het aandeel van ADC Therapeutics SA is verpand.

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Added Pledgee(s)

Name:

Deerfield Partners, L.P.

Address:

780 Third Avenue, 37th Floor, 10017, New York, NY, United States of America (US)

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

Annual Fee

Annual Fee(s) Due Date:

31/03/2025

Grace Period End Date:

30/09/2025

Annual Fee Number:

14

Annual Fee Amount:

800 Euro

Penalty Fee Amount:

400 Euro

Last Annual Payment Date:

20/03/2024

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

700 Euro

Payer:

Mewburn Ellis LLP

	Filing date	Document type	Document Description	Number of pages	File Type
	23/08/2019	Outgoing Correspondence	Letter no formal defects	1	PDF	/0/9/7/4/2/0800424790/docs/ep16190193.9_0_295365l271.pdf
	20/08/2019	Claims	First filed claims	3	PDF	/0/9/7/4/2/0800424790/docs/ep16190193.9_1_claims20190820114557058.pdf